TRAVELLI, Cristina
 Distribuzione geografica
Continente #
EU - Europa 919
NA - Nord America 803
AS - Asia 223
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.946
Nazione #
US - Stati Uniti d'America 786
IE - Irlanda 264
IT - Italia 199
SE - Svezia 137
DE - Germania 133
UA - Ucraina 85
CN - Cina 72
HK - Hong Kong 51
IN - India 49
FI - Finlandia 36
TR - Turchia 30
FR - Francia 23
CA - Canada 17
GB - Regno Unito 16
IR - Iran 10
BE - Belgio 8
VN - Vietnam 8
LT - Lituania 5
RU - Federazione Russa 5
CZ - Repubblica Ceca 4
GR - Grecia 3
CH - Svizzera 1
EU - Europa 1
ID - Indonesia 1
PH - Filippine 1
TH - Thailandia 1
Totale 1.946
Città #
Dublin 264
Jacksonville 163
Dearborn 86
Piemonte 78
Chandler 54
Hong Kong 51
Wilmington 48
Ann Arbor 47
Bremen 28
Lawrence 28
Princeton 28
Beijing 25
Ashburn 20
Ankara 19
San Mateo 17
Toronto 16
Strasbourg 13
Woodbridge 13
Andover 12
Nanjing 12
Kecioeren 10
Formigine 9
Varallo 9
Brussels 8
Dong Ket 8
Hefei 8
Houston 8
Leawood 8
Milan 8
Helsinki 6
Zanjan 6
Berlin 5
Kaunas 5
Torino 5
Albano Laziale 4
Boardman 4
Brno 4
Chengdu 4
Mülheim 4
Nanchang 4
Vaiano Cremasco 4
Athens 3
Bacoli 3
Fairfield 3
Grignasco 3
Guangzhou 3
Shanghai 3
Turin 3
Cagliari 2
Cambridge 2
Dallas 2
Genoa 2
Hangzhou 2
Kunming 2
Monmouth Junction 2
Norwalk 2
Novokuznetsk 2
Omegna 2
Paris 2
Pavia 2
Saluggia 2
Ardabil 1
Auburn Hills 1
Bangalore 1
Baotou 1
Bois-le-roi 1
Changsha 1
Chelyabinsk 1
Como 1
Eskişehir 1
Falkenstein 1
Fuzhou 1
Gravedona 1
Hamilton 1
Hebei 1
Hyderabad 1
Jakarta 1
Jinan 1
London 1
Los Angeles 1
Monza 1
Morlon 1
Novara 1
Nuremberg 1
Occimiano 1
Saint Louis 1
Savignano Sul Rubicone 1
Seattle 1
Shenyang 1
Tehran 1
Volzhskiy 1
Zhengzhou 1
Totale 1.231
Nome #
Identification of a novel NAMPT inhibitor by combinatorial click chemistry and chemical refinement 111
Inhibitors of Nicotinamide Phosphoribosyltransferase, compositions, products and uses thereof. 103
The NAMPT inhibitor FK866 reverts the damage in spinal cord injury 97
Design, synthesis, and biological evaluation of combretabenzodiazepines: a novel class of anti-tubulin agents 94
Identification of Novel Triazole-Based Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors Endowed with Antiproliferative and Antiinflammatory Activity 94
Combretabenzodiazepines: a novel class of antitubulin agents 93
Nicotinamide phosphoribosyltransferase (NAMPT) is over-expressed in melanoma lesions. 90
Targeting Transient Receptor Potential Vanilloid 1 (TRPV1) Channel Softly: The Discovery of Passerini Adducts as a Topical Treatment for Inflammatory Skin Disorders 86
Medicinal chemistry of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors. 79
Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is a tumoural cytokine released from melanoma 77
Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin): a new cytokine in tumour progression 70
Triazole-curcuminoids: A new class of derivatives for 'tuning' curcumin bioactivities? 68
Synthesis and Degradation of Adenosine 5'-Tetraphosphate by Nicotinamide and Nicotinate Phosphoribosyltransferases 67
A novel potent nicotinamide phosphoribosyltransferase inhibitor synthesized via click chemistry 65
Nicotinamide phosphoribosyltransferase (NAMPT) inhibitors: novel modulators of antitumor immunity 64
Increased plasma nicotinamide phosphoribosyltransferase is associated with a hyperproliferative phenotype and restrains disease progression in MPN-associated myelofibrosis 64
Targeting nicotinamide phosphoryltransferase (NAMPT) in inflammatory bowel disease 61
Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin): a new cytokine in tumour progression 59
Extracellular nicotinamide phosphoribosyltransferase, a new cancer metabokine 58
Characterization of NAD uptake in mammalian cells 57
Metabolic regulation of suppressive myeloid cells in cancer 57
NAMPT: A pleiotropic modulator of monocytes and macrophages 56
Nicotinamide phosphoribosyltransferase (NAMPT) inhibitors are novel modulators of myeloid-derived suppressor cells 55
Data on metabolic stability, aqueous solubility and CYP inhibition of novel triazole-based nicotinamide phosphoribosyltransferase (NAMPT) inhibitors 53
The Cytokine Nicotinamide Phosphoribosyltransferase (eNAMPT; PBEF; Visfatin) Acts as a Natural Antagonist of C-C Chemokine Receptor Type 5 (CCR5) 50
NAD depletion by FK866 induces autophagy 49
Reciprocal potentiation of the antitumoral activities of FK866, an inhibitor of nicotinamide phosphoribosyltransferase, and etoposide or cisplatin in neuroblastoma cells 48
Extracellular nicotinamide phosphoribosyltransferase boosts IFNγ-induced macrophage polarization independently of TLR4 25
Insight Into Nicotinamide Adenine Dinucleotide Homeostasis as a Targetable Metabolic Pathway in Colorectal Cancer 25
OXER1 and RACK1-associated pathway: a promising drug target for breast cancer progression 21
Identification of novel aza-analogs of TN-16 as disrupters of microtubule dynamics through a multicomponent reaction 18
NAMPT and NAPRT serum levels predict response to anti-TNF therapy in inflammatory bowel disease 10
Synthesis and Degradation of Adenosine 5'-Tetraphosphate by Nicotinamide and Nicotinate Phosphoribosyltransferases 7
Totale 2.031
Categoria #
all - tutte 7.927
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.927


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20197 0 0 0 0 0 0 0 0 0 0 4 3
2019/2020356 4 1 27 1 52 54 81 17 36 45 37 1
2020/2021243 31 3 29 1 31 21 33 3 35 15 30 11
2021/2022237 19 3 22 21 17 2 14 6 15 15 30 73
2022/2023635 31 23 34 5 50 63 26 34 296 7 38 28
2023/2024177 24 15 35 10 33 0 49 4 3 1 3 0
Totale 2.031